Special delivery: bacterial couriers are smuggling drugs into cancers
This article explores recent scientific advancements in using bacteria as targeted delivery vehicles for cancer drugs. It highlights various research breakthroughs aimed at improving the precision and efficacy of medical treatments.
Why it matters
Improving drug delivery mechanisms is critical for increasing the effectiveness of cancer therapies while minimizing side effects on healthy tissue.
Liam Drew is a freelance science journalist based near London.
Search author on: PubMed Google Scholar
Bluesky Facebook LinkedIn Reddit Whatsapp X Save article View saved research Illustration: Julia Specht represented by Roar Artists
doi: https://doi.org/10.1038/d41586-026-02657-4
This article is part of Nature Outlook: Drug delivery , a supplement produced with financial support from Taiho Oncology, Inc . Nature maintains full independence in all editorial decisions related to the content. About this content .
Batist, G. et al. Cancer Immunol. Immunother. 75 , 60 (2026).
Ballister, E. R. et al. Nature Biotechnol. 43 , 672–676 (2025).
Quispe-Tintaya, W. et al. Proc. Natl Acad. Sci. USA 110 , 8668–8673 (2013).
Chellakkan Selvanesan, B. et al. Sci. Transl. Med. 14 , eabc1600 (2022).
Chien, T. et al. Nature Biomed. Eng. 6 , 94–104 (2022).
Raman, V. et al. Nature Commun. 12 , 6116 (2021).
Redenti, A. et al. Nature 635 , 453–461 (2024).
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in